GS
78
2
SEE
46
2
TROW
58
10
PX
15
2
NTAP
65
4
WM
85
-3
HCP
78
-2
CINF
41
-9
MTB
53
-2
TSCO
66
11
HCA
35
-9
EMC
70
12
TXN
40
4
RIG
50
4
PXD
48
-6
DNB
24
2
AVB
62
-2
LMT
55
-5
APD
32
3
D
33
-4
GS
78
2
SEE
46
2
TROW
58
10
PX
15
2
NTAP
65
4
WM
85
-3
HCP
78
-2
CINF
41
-9
MTB
53
-2
TSCO
66
11
HCA
35
-9
EMC
70
12
TXN
40
4
RIG
50
4
PXD
48
-6
DNB
24
2
AVB
62
-2
LMT
55
-5
APD
32
3
D
33
-4
Financhill
Back

Novo Nordisk A/S Quote, Financials, Valuation and Earnings

MarketBeat Alert: Strong sell signal just issued for these 20 stocks

Go here now to get free instant access to all 20 stocks to sell.
Buy
63

NVO
Novo Nordisk A/S

Last Price:
126.92
Seasonality Move:
5.12%

7 Day Trial

ALL ACCESS PASS

$ 7

This DeFi Coin Could 10x Soon... I Advise You Get In Now!

Discover this DeFi diamond before the next surge

Novo Nordisk A/S Price Quote

$126.92
+0.07 (+0.9%)
(Updated: April 27, 2024 at 6:14 AM ET)

Novo Nordisk A/S Key Stats

Buy
63
Novo Nordisk A/S (NVO) is a Buy
Day range:
$125.99 - $127.90
52-week range:
$75.56 - $138.28
Dividend yield:
1.08%
P/E ratio:
46.92
P/S ratio:
16.91
P/B ratio:
35.77%
Volume:
3.2M
Avg. volume:
3.7M
1-year change:
53.77%
Market cap:
$565.9B
Revenue:
$33.7B
EPS:
$2.7

How Much Does Novo Nordisk A/S Make?

Is Novo Nordisk A/S Growing As A Company?

  • What Is Novo Nordisk A/S's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.44%
  • What Is Novo Nordisk A/S's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.71%

Novo Nordisk A/S Stock Price Performance

  • Did Novo Nordisk A/S Stock Go Up Last Month?
    Novo Nordisk A/S share price went down by -1.98% last month
  • Did NVO's Share Price Rise Over The Last Year?
    NVO share price rose by 53.77% over the past 1 year

What Is Novo Nordisk A/S 52-Week High & Low?

Novo Nordisk A/S Price To Free Cash Flow

Is It Risky To Buy Novo Nordisk A/S?

  • How Much Debt Does Novo Nordisk A/S Have?
    Total long term debt quarterly is $3.2B
  • How Much Cash Does Novo Nordisk A/S Have?
    Cash and short term investments quarterly total is $4.5B
  • What Is Novo Nordisk A/S’s Book Value Per Share?
    Book value per share is 3.55

Is Novo Nordisk A/S Cash Flow Positive?

  • What Is NVO Cash Flow From Operations?
    Cash flow from operations (TTM) is $15.8B
  • What Is Novo Nordisk A/S’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$9.2B
  • What Is Novo Nordisk A/S’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$6.4B

Novo Nordisk A/S Return On Invested Capital

  • Is Management Doing A Good Job?
    NVO return on invested capital is 72.87%
  • What Is Novo Nordisk A/S Return On Assets?
    ROA measures how assets are converting to revenues and is 30.15%
  • What Is NVO Return On Equity?
    ROE is a measure of profitability and is 92.18%

Novo Nordisk A/S Earnings Date & Stock Price

Novo Nordisk A/S Competitors

  • Who Are Novo Nordisk A/S's Competitors?
    Below is a list of companies who compete with Novo Nordisk A/S or are related in some way:
    • Amgen Inc (AMGN)
    • AstraZeneca PLC (AZN)
    • Evaxion Biotech AS (EVAX)
    • Viking Therapeutics Inc (VKTX)
    • Vertex Pharmaceuticals Inc (VRTX)

Novo Nordisk A/S Dividend Yield

Novo Nordisk A/S Analyst Estimates

YoY Growth Past Surprise
EPS: 71.25% 9.34%
Revenue: 43.78% 7.57%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 2
Sell Recommendations: 1
Price Target: 135.65
Upside from Last Price: 6.94%

Major Shareholders

  • How many NVO shares are owned by institutional investors?
    402.2M NVO shares are owned by institutional investors
  • How many NVO shares are owned by insiders?
    0 NVO shares are owned by insiders